Peter Schäfer

14.7k citations
220 papers · 11.4k · 4 hit papers · h-index 56

Impact in

  • Hematology top 0.2%
    • Multiple Myeloma Research and Treatments
  • Immunology top 1%
    • Immune Cell Function and Interaction

Papers in

    • Protein Degradation and Inhibitors 33
    • Ubiquitin and proteasome pathways 14
    • Multiple Myeloma Research and Treatments 45

Peter Schäfer

207 papers receiving 11.0k citations

Peter Schäfer's Hit Papers

Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate T cells by inducing degradation of T cell repressors I karos and A iolos via modulation of the E 3 ubiquitin ligase complex CRL 4 CRBN 2013 · 472 citations
4720+7+14Years since publication200400600

Peers

Peter Schäfer
Comparison fields: 5 of 154
  • Hematology 2.7k
  • Immunology 2.1k
  • Oncology 2.2k
  • Genetics 805
  • Molecular Biology 4.4k
Replace Anders Waage with:
Anders Waage Norway
Hermann-Josef Gröne Germany
Jacqueline Whang‐Peng Taiwan
Zwi Berneman Belgium
Giuseppe Leone Italy
John H. Kersey United States
Bayard D. Clarkson United States
Joel S. Greenberger United States
Christian Peschel Germany
David R. Spriggs United States
Peter Schäfer relative to Anders Waage Norway Anders Waage's profile →
Citations per field
00.5×1.5×2.3×
Anders Waage · 1×
Citations per year

Countries citing papers authored by Peter Schäfer

Since Specialization
Citations

This map shows the geographic impact of Peter Schäfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schäfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schäfer more than expected).

Fields of papers citing papers by Peter Schäfer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Schäfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schäfer. The network helps show where Peter Schäfer may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Schäfer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Schäfer Line = papers co-authored together Peter Schäfer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 220 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
Hit paper breakdown →
2012623
2
Keynote review: Phosphodiesterase-4 as a therapeutic target
Hit paper breakdown →
2005544
3
Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate T cells by inducing degradation of T cell repressors I karos and A iolos via modulation of the E 3 ubiquitin ligase complex CRL 4 CRBN
Hit paper breakdown →
2013472
4
Prolonged Bacterial Culture to Identify Late Periprosthetic Joint Infection: A Promising Strategy
Hit paper breakdown →
2008416
5 2003406
6 2008355
7 2012343
8 2008335
9 2014256
10 2005232
11 2017212
12 2007193
13 2008189
14 2008182
15 1998170
16 2009169
17 2014166
18 2003160
19 2006151
20 1999142

About Peter Schäfer

Peter Schäfer is a scholar working on Molecular Biology, Hematology, Oncology, Immunology and Epidemiology, having authored 220 papers that have together received 11.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (45 papers), Protein Degradation and Inhibitors (33 papers), Ubiquitin and proteasome pathways (14 papers), T-cell and B-cell Immunology (11 papers), Cytomegalovirus and herpesvirus research (11 papers), Chronic Lymphocytic Leukemia Research (11 papers), Hepatitis C virus research (10 papers) and Cancer Treatment and Pharmacology (10 papers). The work is most often cited by research in Hematology (2.7k citations), Immunology (2.1k citations), Oncology (2.2k citations), Genetics (805 citations) and Molecular Biology (4.4k citations). Peter Schäfer has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include George W. Muller, David Stirling, Kam Y. J. Zhang, Miles D. Houslay, Rajesh Chopra, J. Blake Bartlett, Bernd Fink, Rainer Laufs, Lei Wu and Anita K. Gandhi. Their work appears in journals such as Blood, Annals of the Rheumatic Diseases, Journal of Clinical Microbiology, Journal of Clinical Oncology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact